Hey oh purple one, celebrating 10th anniversary with the company (almost longer than marriage lasted).
Yes it has been a bumpy ride. agree with all you have said.
To weigh in on the frustration side of things....
yes we have a seemingly world class product, that out performs the competitors products..however the SP and MC arent reflective of what such a product should be at.
YEs, we have impressive test results yet the SP languishes......we have repeated positive test results yet the SP falls...with a new bigger and more substantial trial about to start and the SP (you can guess the rest).....
From a certain point of view, repeated test results indicating the same success story is exciting, but its just confirming what was allready (anticipated) or known. HAppy to be wrong, but more 'same good news' from the next trial or study wont have a significant impact on SP or MC (in my opinion only).
Preparing for a continued bumpy ride, but in a short (relatively short) period could see the fuse lit to set this off.......but more 'successful' trial results of the same nature may not be what it takes.
AVR Price at posting:
$20.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)